Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nicotinamide, an Inhibitor of PARP-1, for Preventing Delirium in Older Adults

NCT04725253 is registered in ClinicalTrials.gov with University of Chile as lead sponsor.

NCT NCT04725253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04725253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nicotinamide, an Inhibitor of PARP-1, for Preventing Delirium in Older Adults
Lead sponsor
University of Chile
Phase
Not applicable
Overall status
Unknown status
Start date
January 21, 2021
Completion date
April 30, 2022
Enrollment
146 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium confusional state